Navigation Links
Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences
Date:2/22/2011

ping universal influenza and other vaccines in collaboration with scientists from the University of Pennsylvania. Other partners and collaborators include Merck, National Cancer Institute, U.S. Military HIV Research Program, NIH, HIV Vaccines Trial Network, University of Southampton, and PATH Malaria Vaccine Initiative. More information is available at www.inovio.com.

This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene delivery technologies and DNA vaccines and our capital resources. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs (including, but not limited to, the fact that pre-clinical and clinical results referenced in this release may not be indicative of results achievable in other trials or for other indications, that the studies or trials may not be successful or achieve the results desired, that results from one study may not necessarily be reflected or supported by the results of other similar studies and that results from an animal study may not be indicative of results achievable in human studies), the availability of funding to support continuing research and studies in an effort to prove safety and efficacy of electroporation technology as a delivery mechanism or develop viable DNA vaccines, the adequacy of our capital resources, the availability or potential availability of alternative therapies or treatments for the conditions targeted by the company or its collaborators, including alternatives that may be more efficacious or cost-effective than any therapy or treatment that the company and its collaborators hope to develop, evaluation of potential opportunities, issues involving product liability, issues involving patents and whether
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
2. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
3. Inovio Pharmaceuticals Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial
4. Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)...  MedVantx, Inc., the company that has pioneered a ... the Company has completed a major expansion of its ... and the upgrade of its systems to offer a ... specialty home delivery pharmacy in Sioux Falls, ... physicians, health systems and payors novel distribution services, as ...
(Date:5/23/2013)... , May 23, 2013   BioLife Solutions , ... proprietary clinical grade hypothermic storage and ... contract aseptic media manufacturer , today announced its ... Regenerative Medicine Congress 2013 this week in ... ) Dr. Aby J. Mathew, BioLife,s Senior ...
(Date:5/23/2013)... 2013 Ranbaxy Laboratories Limited ... Daiichi Sankyo Co., Ltd. (im Weiteren ... die Maßnahmen bekannt, die Ranbaxy in ... sich der Angelegenheiten der vorhergehenden Unternehmensführung ... Daiichi Sankyo unterstützt Ranbaxy ...
Breaking Medicine Technology:MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3Ranbaxy kündigt Verbesserungen bei Geschäftsstandards und Qualitätssicherungsinitiativen an 2
... HILL, N.C., Dec. 5, 2011   New product launches ... It is critical for organizations to balance the dueling goals ... challenge that executives face is determining how much to invest, ... of the budget for primary care launch is ...
... OrbusNeich today announced that data published in the November ... is safe when accompanied by only 10 days of dual ... 49 patients treated with Genous, no patient had died or ... myocardial infarction or angiographic evidence of stent thrombosis (ST) ascribable ...
Cached Medicine Technology:Launch Spend Insights: Companies Now Invest More in Launch Year Than in Previous 3 Ramp-Up Years Combined 2Data Published in EuroIntervention Indicate that OrbusNeich's Genous™ Stent Is Safe with Very Short-Term Dual Antiplatelet Therapy 2Data Published in EuroIntervention Indicate that OrbusNeich's Genous™ Stent Is Safe with Very Short-Term Dual Antiplatelet Therapy 3
(Date:5/23/2013)... PA (PRWEB) May 23, 2013 Pittsburgh-based ... allowing seniors to remain independent in their own homes ... Security Alert’s Director of Life Safety, recently commented on ... providers. He stated that although there are numerous ... Automated Security Alert is rare in that they are ...
(Date:5/23/2013)... Sunnyvale, CA (PRWEB) May 23, 2013 Footwear ... Dansko Vista Collection of sandals containing cork footbeds. ... Dansko has had consistently good sales for many years, and ... this spring and summer. , Dansko Shoes ... and the Vista Collection is no exception. Containing leather and ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Kitchen ... hands-on cooking classes, the most advanced culinary technique series ... from class with the knowledge of how to purchase, ... and the health benefits of organic, local ingredients. The ... which are six hours each. The next series begins ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 When Teachers ... product donations to raise funds for the Moore, OK ... dollars worth of items that could be sold for ... However, the staff at Teachers Notebook were overwhelmed by ... pledged $1000.00 worth of materials within the first 12 ...
(Date:5/23/2013)... 911 Signal USA is attending the 2013 Police Fleet ... and run through May 24, 2013. , In addition to ... emergency vehicle lights and sirens, 911 Signal USA will ... expo. , The Charger has been equipped with the best ... seen by visiting 911 Signal USA during the expo at ...
Breaking Medicine News(10 mins):Health News:Automated Security Alert's New Medical Alarm Works Even In Power Outages 2Health News:Footwear etc. Announces the New Collection of Dansko Cork Sandals 2Health News:Kitchen on Fire Launches Intermediate Cooking Series, Advancing the Culinary Skills of Experienced Home Chefs 2Health News:Kitchen on Fire Launches Intermediate Cooking Series, Advancing the Culinary Skills of Experienced Home Chefs 3Health News:Teachers Rally to Raise Funds for Moore Tornado Victims 2Health News:911 Signal USA Attends the 2013 Southwest Police Fleet Expo 2
... first Southern-style canned product ... American Heart Association, COLUMBUS, Ohio, Jan. 9 ... low fat and meatless, were the first,product line of ... savory,taste. Now, heart-healthy Sensibly Seasoned products also bear the ...
... can do quite a number on your teeth. Did ... 11 teaspoons of sugar per serving and,that most soft ... these acids can cause erosion, the loss of hard ... Terry, a Pennsylvania Dental Association (PDA),member and endodontist from ...
... WSB-TV Partner to Collect Bags at 25 Georgia Locations, ... private oncology/ hematology practice in the Southeast -- will team,up ... drive. The,event will be held at 25 GCS offices across ... p.m., "Totes 2 Tots" delivers new or nearly new ...
... lead to better prognosis, treatments, researchers say , , WEDNESDAY, ... on a handful of tiny ribonucleic acid (RNA) molecules ... travels to the lung and bone. , These "microRNAs" ... When they are missing, that allows the disease to ...
... combat mortality , , WEDNESDAY, Jan. 9 (HealthDay News) -- ... question the conventional wisdom of treating with corticosteroids, intensive ... called pentastarch. , The first study compared the ... septic shock and found no improvement in survival rates. ...
... of developmental disorder, researchers say , , WEDNESDAY, Jan. 9 (HealthDay ... risk for developing autism, a new study suggests. , The ... of the causes of a disorder that is turning out ... in its symptoms. Not only is autism complicated, its incidence ...
Cached Medicine News:Health News:Glory Foods Receives Heart Healthy Certification 2Health News:Keep a Watchful Eye on Sugary Beverage Consumption 2Health News:Georgia Cancer Specialists to Sponsor Sixth Annual 'Totes 2 Tots' Suitcase Drive for Foster Children 2Health News:Georgia Cancer Specialists to Sponsor Sixth Annual 'Totes 2 Tots' Suitcase Drive for Foster Children 3Health News:Tiny RNA Molecules Control Breast Cancer's Spread 2Health News:Tiny RNA Molecules Control Breast Cancer's Spread 3Health News:Tiny RNA Molecules Control Breast Cancer's Spread 4Health News:Standard Septic Shock Treatments Ineffective 2Health News:Standard Septic Shock Treatments Ineffective 3Health News:Standard Septic Shock Treatments Ineffective 4Health News:Chromosome Abnormalities Raise Risk for Autism 2Health News:Chromosome Abnormalities Raise Risk for Autism 3Health News:Chromosome Abnormalities Raise Risk for Autism 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: